AstraZeneca sells rare cancer drug to Sanofi for up to $300 million | Reuters

ReutersAstraZeneca sells rare cancer drug to Sanofi for up to $300 million | ReutersReutersL), under pressure from falling sales of older drugs, is selling a medicine for a rare type of cancer to Sanofi (SASY.PA) as it continues a drive to raise cash by divesting certain assets. Sanofi's rare diseases division Genzyme will pay AstraZeneca up ...AstraZeneca sells rare cancer drug to Sanofi for up to $300 million - Yahoo ...Yahoo News UKAstraZeneca sells cancer drug to Sanofi for $300m | DigitalLook.comDIGITALLOOKall 13 news articles »

Share this post